A
$ Value
$0
Shares
1,401,650
Price
$0
Filed
Jul 28
Insider
Name
Lin Patrick
Title
Chief Business - Strategy Off
CIK
0001799363
Roles
Officer
Transaction Details
Transaction Date
2025-07-24
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,412,082
Footnotes
Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,384,411 shares are subject to stockholder approval of the revised Omnibus Plan. | Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.
Filing Info
Lin Patrick's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-15 | PCSA | ▲ | $4K ★ |
| 2026-03-31 | PCSA | ▲ | $4K |
| 2026-01-01 | PCSA | M | $0 |
| 2026-01-01 | PCSA | M | $0 |
| 2025-10-01 | PCSA | A | $0 |
| 2025-10-01 | PCSA | A | $0 |
| 2025-07-24 | PCSA | A | $0 |
Other Insiders at PCSA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
SKIBSTED RUSSELL
Chief Financial Officer
|
$12K | — | 2026-04-15 |
|
Ng George K
Chief Executive Officer
|
$11K | — | 2026-04-15 |
|
Bigora Sian
Chief Development Officer
|
$11K | — | 2026-04-15 |
|
Guy Wendy
Chief Administrative Officer
|
$9K | — | 2026-04-15 |
|
Young David
Pres. Research & Development
|
$9K | — | 2026-04-15 |
|
Lin Patrick
Chief Business - Strategy Off
|
$8K | — | 2026-04-15 |
| Baluch Khoso | $6K | — | 2026-03-31 |
| Pannu Geraldine | $5K | — | 2026-03-31 |
| Neal James R | $2K | — | 2026-03-31 |